Tag: Benlysta
-
Benlysta
A belimumab injection (Benlysta) is prescribed with other medications as treatment to patients of systemic lupus erythematosus. This type of medication is known as a monoclonal antibody and acts to block the activity of certain proteins of patients with symptoms of lupus. Benlysta has been shown to be less effective on African-American patients with symptoms…
-
New Trial Testing Benlysta as Injectable
The Lupus Research Institute is pleased to alert people with lupus of a new Phase III trial testing the efficacy, safety and tolerability of the recently approved Benlysta(r) as a once-a-week injectable rather than the existing intravenous formulation. For more information, visit clinicaltrials.gov and search for trial NCT01484496. Full story
-
Benlysta Continues to Gain Increased Market Share among U.S. Rheumatologists Six-Months Post-Launch
More rheumatologists are prescribing Benlysta for lupus The LaunchTrends(R): Benlysta Wave 3 report, which measures product uptake and commercial effectiveness at six months post launch, finds that over half of surveyed rheumatologists have initiated trial on Benlysta, up from 36% at three months post-launch and significantly higher than 25% at one month post-launch. One of…
-
New Lupus Drug Benlysta Approved
The FDA has approved Benlysta, the first new lupus drug since 1955. Benlysta reduces lupus activity; it’s hoped the drug will help patients reduce their need for steroids.
-
New Lupus Treatment Benlysta: FAQ
The FDA has approved Benlysta, the first new drug for lupus in 50 years. What is it? Which patients will benefit? Which won’t? Is it safe? WebMD’s FAQ.
-
Glaxo’s Revolutionary Lupus Treatment Benlysta Now EU Approved
The first treatment developed for lupus in over 50 years has finally been approved by the European Union this week. The watchdog, European Medicines Agency, has backed the injectable drug that will cost Europeans $23,000 USD a year. Already approved in the United States in March 2011, the drug costs Americans $35,000 USD annually. Benlysta’s…